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The chain elongation products from [2-i4C]malonyl-CoA and palmitoyl-CoA by rat liver microsomes 
initiated by NADPH were found mainly to be 18 : 1 and 18 : 0. When anti-NADPH-cytochrome P450 
reductase or anti-cytochrome 65 immunoglobulin G were included in this system, not only was the overall 
chain elongation significantly suppressed, but also a new radioactive product, which was identified as 
2-heptadecanone derived from an intermediate ,&ketostearate, is accumulated depending upon the 
amounts of IgG added. These results suggest hat NADPH-cytochrome P450 reductase and cytochrome 
b5 participate in the conversion from ,&ketostearoyl-CoA to fl-hydroxystearoyl-CoA, which is the first 
reductive step of the microsomal chain elongating system. 
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1. INTRODUCTION 
Liver microsomes catalyze both desaturation 
and chain elongation of fatty acids. Attempts to 
isolate desaturase have shown it to be a multien- 
zyme system containing microsomal electron- 
transfer components [I ,2]. In contrast to the 
desaturase system, relatively little is known about 
the enzymes involved in the chain elongation of 
fatty acids [3]. 
Microsomal electron-transport components, 
NADPH-cytochrome P450 reductase (F,,T) and 
cytochrome 65 (cyt. bs), participate in the fatty 
acid chain elongation initiated by NADPH [4]. 
However, the question of which reductive steps 
participate in the microsomal chain-elongating 
system remains unresolved. These studies were 
done to clarify this problem using antibodies 
against purified FP= and cyt. bs. 
* To whom correspondence should be addressed 
2. EXPERIMENTAL 
2.1. Materials 
The following materials were obtained from 
commercial sources: [2-14C]malonyl-CoA 
(48.9 mCi/mmol) from New England Nuclear; 
NADPH from Kyowa Hakko; malonyl-CoA, 
palmitoyl-CoA, bovine serum albumin, 
cytochrome c (horse heart) and trypsin from 
Sigma; DEAE-cellulose (DE 52) and precoated 
thin-layer plate (LK6DF) from Whatman; 
Sephadex G-100 and 2 ’ ,5 ’ -ADP-Sepharose from 
Pharmacia; Triton X-100 from Wako; fat-free diet 
from Oriental Kobo. All other chemicals were of 
analytical grade. 
2.2. Preparation of microsomes 
Liver microsomes were prepared from refed 
fasted rats as in [5]. The microsomes were washed 
once and suspended in 0.25 M sucrose at 
13-20 mg protein/ml. 
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Table 1 
Effect of rabbit anti-cyt. by and anti-F’,T IgG on condensation reaction and NADPH-initiated fatty acid chain 
elongation 
kG 








Fatty acids ,f?-Ketostearate 2-Hepta- 
decanone 
Preimmune 0 100 100 93.4 3.0 3.6 
1 104.6 107 94.8 0.3 5.0 
5 103.5 126 95.6 0 4.4 
10 104.5 118.3 93.4 0 6.7 
20 88.1 128.9 91.1 0 8.7 
Anti-cyt .b5 1 82.4 80.0 94.1 n.d.a 5.9 
5 102.4 58.0 88.4 n.d. 11.6 
10 97.8 58.2 76.4 n.d. 23.6 
Anti-F,r 1 114.2 113.6 91.8 1.1 7.2 
5 140.6 124.8 78.1 3.1 18.9 
10 115.3 91.7 78.2 1.2 20.6 
20 104.7 56.3 70.1 1.6 28.3 
a n.d., not detected 
2.3. Enzyme assays 
Microsomal overall chain elongation and con- 
densation reactions were measured by the incor- 
poration of [2-r4C]malonyl-CoA (1.2 mCi/mmol) 
into fatty acids in the presence of palmitoyl-CoA 
by the assay conditions in [6]. To separate the 
radioactive reaction products, the organic solvent 
extract was applied on a thin-layer plate and 
developed with petroleum ether/ethyl ether/acetic 
acid (70: 30: 1, by vol.) [7]. The fractions cor- 
responding to authentic P-ketostearic acid, 
2-heptadecanone and fatty acids were scraped into 
scintillation vials, and 10 ml of Toluene-based 
mixture were added. Radioactivity was determined 
using an Aloka liquid scintillation spectrometer. 
Further identification of the reaction products was 
achieved by radio gas-liquid chromatography 
after methylation with diazomethane. 
To examine the effects of antibodies on chain 
elongation and condensation reactions, IgG was 
added to the microsomes, preincubated at 30°C 
for 10 min and then centrifuged at 77000 x g for 
90 min to remove any unbound antibodies. The 
resulting microsomal pellets were suspended in 
0.25 M sucrose and used for enzyme assay. 
NADH- and NADPH-cytochrome c reductase 
activity were determined as in [8]. 
2.4. Preparation of anti-cyt. b5 and anti-Fp;,r 
antibodies 
Cytochrome bs was purified to homogeneity 
from rat liver microsomes as in [9]. NADPH- 
cytochrome P450 reductase (Fpr) was purified 
from rat liver microsomes as in [lo] followed 
by use of 2’S’-ADP-Sepharose affinity 
chromatography [l 11. Purity of the final prepara- 
tion was confirmed by SDS disc gel electrophoresis 
[ISI. 
Immunization of rabbits and purification of im- 
munoglobulin G (IgG) were done as in [12]. The 
titer of antiserum was checked by Ouchterlony 
double immunodiffusion [ 131. Anti-F,r IgG in- 
hibited NADPH-cytochrome c reductase activity 
by 80% at 2 mg IgG/mg microsomal protein, 
whereas anti-cyt. bs IgG inhibited NADH- 
cytochrome c reductase by 70% at 10 mg IgG/mg 
microsomal protein. 
12 
Volume 155, number 1 FEBS LETTERS May 1983 
2.5. Analytical methods 
Protein was measured as in [14] with bovine 
serum albumin as a standard. Polyacrylamide disc 
gel electrophoresis was done as in [15]. 
3. RESULTS 
3.1. Effects of rabbit anti-cyt. bs and anti-F,T ZgG 
on NADPH-initiated microsomal fatty-acid 
chain elongation and condensation reactions 
Preincubation of microsomes with the an- 
tibodies suppressed significantly the overall chain 
elongating reaction in either anti-cyt. bs- or anti- 
FP-r IgG (table 1). However, the two antibodies had 
no effect on the condensation reaction. Separation 
of the components of the reaction products after 
saponification revealed an accumulation of 
2-heptadecanone, when microsomes were pre- 
incubated with the antibodies. 2-Heptadecanone is 
suggested to be a decarboxylated erivative of an 
intermediate, P-ketostearate, formed during 
saponification of the reaction products [7,17]. 
Here, a further experiment o verify the origin of 
2-heptadecanone was done using the initial con- 
densation product, ,&ketostearate, which was ob- 
tained from the whole reaction system without the 
addition of NADPH. Results of radio gas-liquid 
chromatography suggested the sample prepared by 
saponification and extraction from the condensa- 
tion product to be 2-heptadecanone (fig.lA), 
which was subsequently identified positively as 
such by gas chromatography-mass pectrometry 
(GC-MC) (not shown). 
3.2. Radio gas-liquid chromatography of the 
reaction products 
The reaction products were analyzed in greater 
detail by radio gas-liquid chromatography in the 
presence or absence of antibodies, because the fat- 
ty acids could not be separated by thin-layer 
chromatography (section 2.3). In the preimmune 
control IgG, two major radioactive peaks, the 
larger 18 : 1 and the smaller 18 : 0, were observed as 
a result of the elongation and subsequent desatura- 
tion (fig.lB). However, addition of anti-cyt. 65 
IgG made a remarkable change as compared with 
that of control IgG. The 18: 1 peak disappeared 
completely and another new radioactive peak 
clearly appeared, while the major peak was 18 : 0 
(fig.1). The new radioactive peak was identified as 
0 5 10 15 
Time (min.) 
Fig. 1. Radio gas-liquid chromatography of the reaction 
products in the presence or absence of anti-cyt. b5 anti- 
bodies. The microsomes were preincubated with the 
preimmune or anti-cyt. bs IgG as in section 2. The reac- 
tion products were methylated by diazomethane after 
saponification with 10’70 KOH in methanol for 30 min 
and applied to a radio gas-liquid chromatography 
(Hitachi 663) equipped with a 2 m stainless steel column 
containing 10% EGSSX. The column was programmed 
to 160-200°C at S”C/min. (A) Condensation product in 
the absence of IgG and NADH; (B) chain elongation 
product in the presence of preimmune IgG; (C) chain 
elongation product in the presence of anti-cyt. b5 IgG. 
The amount of IgG added was 10 mg/mg microsomal 
protein: (-) gas chromatographic trace; (-) 
radioactivity trace. 
2-heptadecanone by GC-MS as described above 
(not shown). The ketone accumulation increased 
depending upon the amount of antibodies added. 
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4. DISCUSSION 
The hepatic microsomal fatty acid elongation 
reaction requires fatty acyl-CoA as a precursor, 
malonyl-CoA as a 2-carbon donor and reducing 
equivalents provided by either NADH or NADPH 
[16,17]. Recent studies have shown the involve- 
ment of cyt. bs in the transfer from NADH to an 
elongase nzyme system [181 and of Fpr and cyt. 65 
in the transfer from NADPH [4]. The NADPH- 
dependent elongation reaction may occur via two 
pathways [4] : 
(i) Through cyt. bs via Fpr; 
(ii) Directly to the elongase from Frr. 
The precise mechanism, however, remains to be 
resolved. For the elongation of fatty acids by 
2-carbon unit, 2 different reductive steps must oc- 
cur in the process [7]. Up to the present, the reduc- 
tive steps in which the microsomal electron- 
transport components participate have been 
unclear. These investigations revealed an ac- 
cumulation of 2-heptadecanone derived from p- 
ketostearate when incubation was done with either 
anti-cyt. bs or anti-F,r IgG. This finding suggests 
that the participation of cyt. bs and FPr might be 
in the step of ,&ketoacyl-CoA reduction, which is 
the first reductive step in the chain elongating 
system. 
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